Teprotumumab and Hyperglycemia Guidelines to Monitor for Hyperglycemia in Teprotumumab
- 7 July 2021
- journal article
- letter
- Published by Wolters Kluwer Health in Ophthalmic Plastic & Reconstructive Surgery
- Vol. 37 (4) , 393
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Teprotumumab for the Treatment of Active Thyroid Eye DiseaseNew England Journal of Medicine, 2020
- Teprotumumab for Thyroid-Associated OphthalmopathyNew England Journal of Medicine, 2017
- Hyperglycemia Associated With Targeted Oncologic Treatment: Mechanisms and ManagementThe Oncologist, 2016
- Early Identification of Individuals with Poorly Controlled Diabetes Undergoing Elective Surgery: Improving A1c Testing in the Preoperative PeriodEndocrine Practice, 2015
- NHS Diabetes guideline for the perioperative management of the adult patient with diabetes*Diabetic Medicine, 2012